Tumor-infiltrating CD83-positive DCs are of great importance in initiating the primary antitumor immune response and are confirmed as an independent, immunologic prognostic parameter for survival in patients with various types of cancers [17,18,19,20]. The gene discussed is CD83; the disease is neoplasm.